Status:
TERMINATED
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
Midwest Medical Isotopes
Conditions:
Brain Tumor
Eligibility:
All Genders
18-99 years
Brief Summary
The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of n...
Detailed Description
In this study, 35 patients will be selected to undergoing sequential imaging with FLT-PET. Prior to surgical resection, patients will undergo a preliminary FLT-PET. Additional FLT scans for a maximum ...
Eligibility Criteria
Inclusion
- 18 years or older
- Women must not be pregnant or breast feeding
- Histologic or strong radiologic suspicion of high grade malignant glioma or ogliometastatic tumor(s)
Exclusion
- May not have received previous therapy for their malignancy
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00775320
Start Date
October 1 2008
End Date
August 1 2010
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104